Follow on Google News News By Tag * Cambridge Healthtech Institute * Pathology * Molecular Diagnostics * Cancer * Life Science * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Cambridge Healthtech Institute Announces its Latest Advances in Molecular Pathology Short CourseCHI's Latest Advances in Molecular Pathology Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at The Moscone North Convention Center in San Francisco.
Featured Speakers Include: • Iris Schrijver, M.D., Associate Professor of Pathology and Pediatrics; Director, Molecular Pathology Laboratory, Stanford University Medical Center, Lucile Packard Children’s Hospital • Athena Cherry, Ph.D., Director, Cytogenetics Laboratory; Professor, Pathology and Pediatrics, Stanford Comprehensive Cancer Center • Madhuri Hegde, Ph.D., FACMG, Associate Professor, Senior Director, Emory Genetics Laboratory, Department of Human Genetics, Emory University School of Medicine Discussion Topics: • Methodology and use of chromosomal analysis • FISH methods, probe strategies and FISH panels • FISH for use in pathological diagnosis and treatment • aCGH methods and use Advance registration discounts are available until January 11, 2013. To view a detailed agenda and to register, please visit http://www.triconference.com/ To inquire about sponsoring and/or exhibiting, contact Jon Stroup at 781-972-5483 or jstroup@healthtech.com, or Joseph Vacca at 781-972-5431 or jvacca@healthtech.com. Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com. About Cambridge Healthtech Institute (www.healthtech.com) Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and Cambridge Healthtech Media Group. Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. About Molecular Med Tri-Conference 2013 (www.triconference.com) The 20th International Molecular Med Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints. Join over 3,000 of your colleagues in interactive lectures, discussions, and various networking receptions to hear differing views and perspectives on poignant issues facing you and our industry today. Spanning five days, the Tri-Conference includes 5 Concurrent Symposia, the Emerging Molecular Diagnostics Partnering Forum, 15 Afternoon & Dinner Short Courses and 15 Conference Programs. Contact: Laura Norton Cambridge Healthtech Institute lnorton@healthtech.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|